# Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair

> **NCT06100315** · — · ACTIVE_NOT_RECRUITING · sponsor: **Assiut University** · enrollment: 60 (actual)

## Conditions studied

- Complication Following Peripheral Nerve Block

## Interventions

- **DRUG:** Nalbuphine

## Key facts

- **NCT ID:** NCT06100315
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-31
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06100315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06100315, "Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06100315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*